BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15850824)

  • 1. Muscarinic receptor subtype pharmacology and physiology.
    Eglen RM
    Prog Med Chem; 2005; 43():105-36. PubMed ID: 15850824
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscarinic acetylcholine receptors as CNS drug targets.
    Langmead CJ; Watson J; Reavill C
    Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
    Eglen RM
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of muscarinic receptor subtypes.
    Eglen RM
    Handb Exp Pharmacol; 2012; (208):3-28. PubMed ID: 22222692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors: focus on presynaptic mechanisms and recently developed novel agonists and antagonists.
    Grimm U; Moser U; Mutschler E; Lambrecht G
    Pharmazie; 1994 Oct; 49(10):711-26. PubMed ID: 7816897
    [No Abstract]   [Full Text] [Related]  

  • 6. Muscarinic receptor agonists and antagonists: effects on inflammation and immunity.
    Verbout NG; Jacoby DB
    Handb Exp Pharmacol; 2012; (208):403-27. PubMed ID: 22222708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptor agonists and antagonists: effects on keratinocyte functions.
    Grando SA
    Handb Exp Pharmacol; 2012; (208):429-50. PubMed ID: 22222709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
    Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
    Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A muscarinic cholinergic mechanism underlies activation of the central pattern generator for locust flight.
    Buhl E; Schildberger K; Stevenson PA
    J Exp Biol; 2008 Jul; 211(Pt 14):2346-57. PubMed ID: 18587129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
    Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A
    J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic acetylcholine receptors: novel opportunities for drug development.
    Kruse AC; Kobilka BK; Gautam D; Sexton PM; Christopoulos A; Wess J
    Nat Rev Drug Discov; 2014 Jul; 13(7):549-60. PubMed ID: 24903776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal.
    Santafé MM; Lanuza MA; Garcia N; Tomàs M; Tomàs J
    Neuroscience; 2007 Aug; 148(2):432-40. PubMed ID: 17681697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
    Honda H; Tomizawa M; Casida JE
    J Agric Food Chem; 2007 Mar; 55(6):2276-81. PubMed ID: 17319687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.
    Hughes AD; Chin KH; Dunham SL; Jasper JR; King KE; Lee TW; Mammen M; Martin J; Steinfeld T
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1354-8. PubMed ID: 21310610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic opportunities for muscarinic receptors in the central nervous system.
    Felder CC; Bymaster FP; Ward J; DeLapp N
    J Med Chem; 2000 Nov; 43(23):4333-53. PubMed ID: 11087557
    [No Abstract]   [Full Text] [Related]  

  • 17. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
    Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the pharmacology, localization, and structure of muscarinic acetylcholine receptors.
    Brann MR; Jørgensen HB; Burstein ES; Spalding TA; Ellis J; Jones SV; Hill-Eubanks D
    Ann N Y Acad Sci; 1993 Dec; 707():225-36. PubMed ID: 9137555
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic opportunities from muscarinic receptor research.
    Eglen RM; Choppin A; Watson N
    Trends Pharmacol Sci; 2001 Aug; 22(8):409-14. PubMed ID: 11479003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic acetylcholine receptors.
    Ishii M; Kurachi Y
    Curr Pharm Des; 2006; 12(28):3573-81. PubMed ID: 17073660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.